5/1/2014 9:20:40 AM
TEL-AVIV, Israel, May 1, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage proprietary drugs for the treatment of inflammatory and gastrointestinal diseases including cancer and related conditions, today announced that Adi Frish, RedHill's Senior VP Business Development and Licensing, will be presenting at the ChinaBio Partnering Forum 2014, on Wednesday, May 7, 2014, at 15:15 CST. The conference will be held at Kempinski Hotel Suzhou, in Suzhou, China.
Help employers find you! Check out all the jobs and post your resume.
comments powered by